Fungal and Viral Infections After Allogeneic Hematopoietic Transplantation from Unrelated Donors in Adults: Improving Outcomes over Time

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2014 Oct 28

PMID 25347007

Citations 4

Authors

R Parody

R Martino

R de la Camara

A Garcia-Noblejas

A Esquirol

I Garcia-Cadenas

T Villaescusa

D Caballero

M Rovira

F Fernandez-Aviles

F J Marquez-Malaver

I Espigado

C Castilla-Llorente

I Heras

M A Cabero

J R Cabrera

P Barba

D Valcarcel

I Sanchez-Ortega

R F Duarte

D Serrano

F Carretero

L Vazquez

Affiliations

Soon will be listed here.

Abstract

Umbilical cord blood (CB) is increasingly used as an alternative source of stem cells in adult unrelated transplantation. Although registry studies report similar overall outcomes in comparison with BM/PB, comparative studies focusing on severe infections and infection-RM (IRM) with a long follow-up are scarce. A total of 434 consecutive unrelated transplants (1997-2009) were retrospectively analyzed to compare overall outcomes, incidence and risk factors of severe viral and invasive fungal infections in CB (n=65) vs BM/PB recipients (n=369). The 5-year OS was 38 vs 43%, respectively (P=0.2). CB transplantation (CBT) was associated with a higher risk of invasive aspergillosis (100-days-cumulative incidence 16 vs 6%, P=0.04) and CMV infection without differences in RM. No statistically significant differences were found regarding NRM (NRM of 38% in CB vs 37% in BM/PB at 1 year) nor IRM (30% in CB vs 27% in BM/PB at 1 year). In the overall population, NRM and IRM improved in more recent years. In adults who receive a single CBT, the risk of severe infections is increased when compared with unrelated BM/PB recipients, but mortality from infections is similar, leading to similar NRM and survival.

Citing Articles

Major discrepancy between clinical diagnosis of death and anatomopathological findings in adolescents with chronic diseases during 18-years.

Ribeiro M, Duarte-Neto A, Dolhnikoff M, Lindoso L, Lourenco B, Marques H Clinics (Sao Paulo). 2023; 78:100184.

PMID: 36972631 PMC: 10091384. DOI: 10.1016/j.clinsp.2023.100184.

Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.

Rosillo C, Avila A, Huang Y, Devlin S, Cho C, Montoro J Transpl Infect Dis. 2018; 20(4):e12897.

PMID: 29668073 PMC: 6913888. DOI: 10.1111/tid.12897.

Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.

Anand S, Thomas S, Hyslop T, Adcock J, Corbet K, Gasparetto C Biol Blood Marrow Transplant. 2017; 23(7):1151-1157.

PMID: 28392378 PMC: 5846194. DOI: 10.1016/j.bbmt.2017.04.001.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

Ballen K, Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M Biol Blood Marrow Transplant. 2016; 22(9):1636-1645.

PMID: 27343716 PMC: 5008458. DOI: 10.1016/j.bbmt.2016.06.012.

References

De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21. PMC: 2671227. DOI: 10.1086/588660. View

Mikulska M, Raiola A, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T . CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. Biol Blood Marrow Transplant. 2011; 18(1):92-9. DOI: 10.1016/j.bbmt.2011.05.015. View

Saavedra S, Sanz G, Jarque I, Moscardo F, Jimenez C, Lorenzo I . Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant. 2002; 30(12):937-43. DOI: 10.1038/sj.bmt.1703764. View

Sullivan K, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S . Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991; 28(3):250-9. View

Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004; 351(22):2276-85. DOI: 10.1056/NEJMoa041469. View

Iacobelli S . Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2013; 48 Suppl 1:S1-37. DOI: 10.1038/bmt.2012.282. View

McCann S, Byrne J, Rovira M, Shaw P, Ribaud P, Sica S . Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant. 2004; 33(5):519-29. DOI: 10.1038/sj.bmt.1704380. View

Sanz J, Boluda J, Martin C, Gonzalez M, Ferra C, Serrano D . Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transplant. 2012; 47(10):1287-93. DOI: 10.1038/bmt.2012.13. View

Barker J, Davies S, DeFor T, Ramsay N, Weisdorf D, Wagner J . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001; 97(10):2957-61. DOI: 10.1182/blood.v97.10.2957. View

10.

Ljungman P, Griffiths P, Paya C . Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002; 34(8):1094-7. DOI: 10.1086/339329. View

11.

Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H . Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis. 2013; 57(5):671-81. DOI: 10.1093/cid/cit358. View

12.

Garrigue I, Boucher S, Couzi L, Caumont A, Dromer C, Neau-Cransac M . Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol. 2006; 36(1):72-5. DOI: 10.1016/j.jcv.2006.01.002. View

13.

Klein J, Rizzo J, Zhang M, Keiding N . Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant. 2002; 28(11):1001-11. DOI: 10.1038/sj.bmt.1703271. View

14.

Sukdolak C, Tischer S, Dieks D, Figueiredo C, Goudeva L, Heuft H . CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. Biol Blood Marrow Transplant. 2013; 19(10):1480-92. DOI: 10.1016/j.bbmt.2013.07.015. View

15.

Bautista G, Cabrera J, Regidor C, Fores R, Garcia-Marco J, Ojeda E . Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplant. 2008; 43(5):365-73. DOI: 10.1038/bmt.2008.329. View

16.

Klein J, Rizzo J, Zhang M, Keiding N . Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001; 28(10):909-15. DOI: 10.1038/sj.bmt.1703260. View

17.

Saavedra S, Jarque I, Sanz G, Moscardo F, Jimenez C, Martin G . Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect. 2002; 8(11):725-33. DOI: 10.1046/j.1469-0691.2002.00458.x. View

18.

Bacigalupo A, Sormani M, Lamparelli T, Gualandi F, Occhini D, Bregante S . Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica. 2004; 89(10):1238-47. View

19.

Kim S, Kee S, Lee D, Choi S, Park S, Kwon J . Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens. Transpl Infect Dis. 2012; 15(1):49-59. DOI: 10.1111/tid.12003. View

20.

Ninin E, Milpied N, Moreau P, Andre-Richet B, Morineau N, Mahe B . Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis. 2001; 33(1):41-7. DOI: 10.1086/320871. View